CytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last year

Like
Comment
Favorite

CytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last year

TIPRANKS03-31

Product revenue was $9.2M, an increase of 25% compared to $7.3M in Q4 2023. Dr. Phillip Chan, CEO of CytoSorbents (CTSO), stated, “We delivered a s...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

抱歉，当前请求异常(-1)

7x24

All

12:52
Saudi Azm - Project Value Exceeds 5% of 2024 Total Revenue
12:52
Saudi Azm - Announces Project Award With Royal Commission for Riyadh City
12:48
Seacon Shipping Says Unit to Acquire the Vessel by Exercising Purchase Option
12:48
Seacon Shipping Says Unit to Sell a Chemical/Oil Carrier for $32.9 Mln
11:49
South Korea's Posco Group Is Considering Joining Hyundai Steel's $5.8 Billion Steel Plant in Louisiana, U.S. - Reports

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2524972159?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-04-01 04:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524972159","market":"fut","top_or_hot":-1,"title":"CytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last year","media":"TIPRANKS","content":"<div>\n<p>Product revenue was $9.2M, an increase of 25% compared to $7.3M in Q4 2023. Dr. Phillip Chan, CEO of CytoSorbents (CTSO), stated, “We delivered a s...</p>\n\n<a href=\"https://www.tipranks.com/news/the-fly/cytosorbents-reports-q4-adjusted-eps-3c-vs-17c-last-year?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n","source":"tipranks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-01 04:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/the-fly/cytosorbents-reports-q4-adjusted-eps-3c-vs-17c-last-year?utm_source=itigerup.com&utm_medium=referral><strong>TIPRANKS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Product revenue was $9.2M, an increase of 25% compared to $7.3M in Q4 2023. Dr. Phillip Chan, CEO of CytoSorbents (CTSO), stated, “We delivered a s...</p>\n\n<a href=\"https://www.tipranks.com/news/the-fly/cytosorbents-reports-q4-adjusted-eps-3c-vs-17c-last-year?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.tipranks.com/news/the-fly/cytosorbents-reports-q4-adjusted-eps-3c-vs-17c-last-year?utm_source=itigerup.com&utm_medium=referral","article_id":"2524972159","we_media_id":null,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cytosorbents-reports-q4-adjusted-eps-3c-vs-17c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2524972159","pubTimestamp":1743452434,"columns":[],"sourceInfo":{"source_id":"tipranks_highlight","name":"Tipranks"},"weMediaInfo":null,"summary":"Product revenue was $9.2M, an increase of 25% compared to $7.3M in Q4 2023. Dr. Phillip Chan, CEO of CytoSorbents (CTSO), stated, “We delivered a s...","collect":0,"end_time":0,"defaultTopTitle":"tipranks.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","CTSO":"Cytosorbents Corporation"},"translate_title":"CytoSorbents报告第四季度调整后每股收益(3c)与去年(17c)","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CTSO":1},"content_text":"Product revenue was $9.2M, an increase of 25% compared to $7.3M in Q4 2023. Dr. Phillip Chan, CEO of CytoSorbents (CTSO), stated, “We delivered a s...","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}